The recommendations of Wall Street analysts are often relied on by investors when deciding whether t

Medtronic plc (NYSE:MDT) to release Q1 earnings on Sept. 1. Analysts expect $1.39/share, revenue of

TD Cowen analyst Joshua Jennings maintains Medtronic (NYSE:MDT) with a Buy and raises the price t

Medtronic plc (NYSE:MDT) will release its first earnings report before the opening bell on Tuesday,

Medtronic plc (NYSE: MDT) will release Q1 earnings on Sept. 1. Analysts predict $1.39 EPS and $9.54B

MDT's Cardiovascular gains and renal denervation growth offer upside, but tariffs and currency headw

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Beyond analysts' top-and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of

Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and raises the price target

Intuitive Surgical leads surgical robotics with faster procedure growth and recurring revenue, while

Medtronic's Q1 results may reflect strong growth across Cardiovascular, Neuroscience and Diabetes, b

In the latest trading session, Medtronic (MDT) closed at $91.22, marking a -1.81% move from the prev

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Ally Financial Inc. acquired a new position in shares of Medtronic PLC (NYSE: MDT) during the second

Alpine Woods Capital Investors LLC acquired a new stake in Medtronic PLC (NYSE: MDT) during the unde

Medtronic is rated a 'Buy,' favored for its attractive valuation and potential upside from its CAS s

BlackRock Inc. lifted its position in shares of Medtronic PLC (NYSE: MDT) by 0.7% in the undefined q

GALWAY, Ireland, Aug. 20, 2026 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on

Medtronic is reiterated as a "Buy," with shares offering over 10% fundamental upside and attractive

Capital Analysts LLC boosted its stake in Medtronic PLC (NYSE: MDT) by 5.8% in the second quarter, a

Fox Run Management L.L.C. lifted its stake in Medtronic PLC (NYSE: MDT) by 364.9% in the undefined q

In the most recent trading session, Medtronic (MDT) closed at $92.09, indicating a +1.64% shift from

SpaceX seems promising, but the stock looks too expensive at current levels. Intuitive Surgical has

Investors looking for stocks in the Medical - Products sector might want to consider either Medtroni

Representative Richard McCormick (Republican-Georgia) recently sold shares of Walmart Inc. (NASDAQ:

BCS Private Wealth Management Inc. decreased its holdings in shares of Medtronic PLC (NYSE: MDT) by

During market turbulence, investors turn to dividend-yielding stocks. Benzinga provides analyst rati

Additionally, in recognition of the critical unmet need for ventricular arrhythmia treatments, the U

UBS analyst Priya Sachdeva upgrades Medtronic (NYSE:MDT) from Neutral to Buy and raises the price

In times of market turbulence, dividend-yielding stocks are popular for investors. Check out analyst

The medical robot maker expects to report a profit of 28 million yuan to 40 million yuan for the fir

Investors turn to dividend-yielding stocks during market turbulence. Benzinga's Analyst Stock Ra

https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/pulmonary-valve-catheter

TD Cowen analyst Joshua Jennings maintains Medtronic (NYSE:MDT) with a Buy and lowers the price t

Evercore ISI Group analyst Vijay Kumar maintains Medtronic (NYSE:MDT) with a Outperform and lower

Investors turn to dividend-yielding stocks in turbulent markets. Benzinga offers latest analyst rati

The Nasdaq 100 has tripled since 2020, but 10 mega-caps still trade below pre-Covid levels. Who'

During market turbulence, investors turn to dividend-yielding stocks. Benzinga offers latest analyst

Goldman Sachs analyst David Roman maintains Medtronic (NYSE:MDT) with a Neutral and lowers the pr

Bernstein analyst Lee Hambright maintains Medtronic (NYSE:MDT) with a Outperform and lowers the p

BTIG upgrades Medtronic (MDT) to Buy with a $90 target after a strong Q4 revenue beat and accelerati

UBS analyst Priya Sachdeva maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price tar

RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Outperform and maintains

Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and lowers t

Leerink Partners analyst Mike Kratky maintains Medtronic (NYSE:MDT) with a Outperform and lowers

Baird analyst David Rescott maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price ta

Mizuho analyst Anthony Petrone maintains Medtronic (NYSE:MDT) with a Outperform and lowers the pr

Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target

Medtronic (MDT) stock jumps after beating Q4 revenue expectations, driven by strong growth in cardio

Medtronic (NYSE:MDT) reported quarterly earnings of $1.55 per share which beat the analyst consensus